119 related articles for article (PubMed ID: 11746188)
41. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.
Abbas Q; Ashraf Z; Hassan M; Nadeem H; Latif M; Afzal S; Seo SY
Drug Des Devel Ther; 2017; 11():2029-2046. PubMed ID: 28740364
[TBL] [Abstract][Full Text] [Related]
42. Novel synthetic kojic acid-methimazole derivatives inhibit mushroom tyrosinase and melanogenesis.
Chen MJ; Hung CC; Chen YR; Lai ST; Chan CF
J Biosci Bioeng; 2016 Dec; 122(6):666-672. PubMed ID: 27353860
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of UVA-mediated melanogenesis by ascorbic acid through modulation of antioxidant defense and nitric oxide system.
Panich U; Tangsupa-a-nan V; Onkoksoong T; Kongtaphan K; Kasetsinsombat K; Akarasereenont P; Wongkajornsilp A
Arch Pharm Res; 2011 May; 34(5):811-20. PubMed ID: 21656367
[TBL] [Abstract][Full Text] [Related]
44. Biological activities and safety data of kojic acid and its derivatives: A review.
Zilles JC; Dos Santos FL; Kulkamp-Guerreiro IC; Contri RV
Exp Dermatol; 2022 Oct; 31(10):1500-1521. PubMed ID: 35960194
[TBL] [Abstract][Full Text] [Related]
45. Effect of the combination of different depigmenting agents in vitro.
Martínez-Gutiérrez A; Asensio JA; Aran B
J Cosmet Sci; 2014; 65(6):365-75. PubMed ID: 25898763
[TBL] [Abstract][Full Text] [Related]
46. Intervention of sulfur mustard toxicity by downregulation of cell proliferation and metabolic rates.
Ray R; Benton BJ; Anderson DR; Byers SL; Petrali JP
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S87-91. PubMed ID: 11428650
[TBL] [Abstract][Full Text] [Related]
47. Ficus deltoidea (Mas cotek) extract exerted anti-melanogenic activity by preventing tyrosinase activity in vitro and by suppressing tyrosinase gene expression in B16F1 melanoma cells.
Oh MJ; Hamid MA; Ngadiran S; Seo YK; Sarmidi MR; Park CS
Arch Dermatol Res; 2011 Apr; 303(3):161-70. PubMed ID: 20981431
[TBL] [Abstract][Full Text] [Related]
48. Modulation of sulfur mustard induced cell death in human epidermal keratinocytes using IL-10 and TNF-alpha.
Qabar A; Nelson M; Guzman J; Corun C; Hwang BJ; Steinberg M
J Biochem Mol Toxicol; 2005; 19(4):213-25. PubMed ID: 16173061
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of 2-amino-3H-phenoxazin-3-one on the melanogenesis of murine B16 melanoma cell line.
Miyake M; Yamamoto S; Sano O; Fujii M; Kohno K; Ushio S; Iwaki K; Fukuda S
Biosci Biotechnol Biochem; 2010; 74(4):753-8. PubMed ID: 20445320
[TBL] [Abstract][Full Text] [Related]
50. Kojic acid, a potential inhibitor of NF-kappaB activation in transfectant human HaCaT and SCC-13 cells.
Moon KY; Ahn KS; Lee J; Kim YS
Arch Pharm Res; 2001 Aug; 24(4):307-11. PubMed ID: 11534762
[TBL] [Abstract][Full Text] [Related]
51. Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
Prezioso JA; Damodaran KM; Wang N; Bloomer WD
Biochem Pharmacol; 1993 Jan; 45(2):473-81. PubMed ID: 8435097
[TBL] [Abstract][Full Text] [Related]
52. Discovery of Novel Diesters Incorporating Kojic Acid With NSAIDs and Palmitic Acid as Dual Inhibitor of Melanogenesis and Inflammation.
Moharir S; Khobragade P; Rane R; Suryawanshi M; Pal K; Gawade B; Kumar D; Satpute B
J Pharm Sci; 2024 Jul; 113(7):1769-1778. PubMed ID: 38663499
[TBL] [Abstract][Full Text] [Related]
53. Tyrosinase inhibition by extracts and constituents of Sideroxylon inerme L. stem bark, used in South Africa for skin lightening.
Momtaz S; Mapunya BM; Houghton PJ; Edgerly C; Hussein A; Naidoo S; Lall N
J Ethnopharmacol; 2008 Oct; 119(3):507-12. PubMed ID: 18573327
[TBL] [Abstract][Full Text] [Related]
54. Application of FTIR microspectroscopy for characterization of biomolecular changes in human melanoma cells treated by sesamol and kojic acid.
Srisayam M; Weerapreeyakul N; Barusrux S; Tanthanuch W; Thumanu K
J Dermatol Sci; 2014 Mar; 73(3):241-50. PubMed ID: 24296160
[TBL] [Abstract][Full Text] [Related]
55. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
[TBL] [Abstract][Full Text] [Related]
56. Effect of intracellular calcium modulation on sulfur mustard cytotoxicity in cultured human neonatal keratinocytes.
Sawyer TW; Hamilton MG
Toxicol In Vitro; 2000 Apr; 14(2):149-57. PubMed ID: 10793293
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells.
Karakaya G; Ercan A; Oncul S; Aytemir MD
Anticancer Agents Med Chem; 2018; 18(15):2137-2148. PubMed ID: 29607787
[TBL] [Abstract][Full Text] [Related]
58. The role of NAD+ depletion in the mechanism of sulfur mustard-induced metabolic injury.
Martens ME; Smith WJ
Cutan Ocul Toxicol; 2008; 27(1):41-53. PubMed ID: 18330833
[TBL] [Abstract][Full Text] [Related]
59. A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol.
Choi J; Bae SJ; Ha YM; No JK; Lee EK; Lee JS; Song S; Lee H; Suh H; Yu BP; Chung HY
Bioorg Med Chem Lett; 2010 Aug; 20(16):4882-4. PubMed ID: 20619644
[TBL] [Abstract][Full Text] [Related]
60. Tiered approach for evaluation of anti-melanogenic activity of trans-N-coumaroyltyramine derivatives.
Boonjing S; Pongrakhananon V; Sittiwong W; Arunrungvichian K; Maniratanachote R; Chetprayoon P
Exp Dermatol; 2022 Aug; 31(8):1177-1187. PubMed ID: 35325487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
